Issue 12, 2022

A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras

Abstract

Click chemistry was utilised to prepare a library of PROTACs based on entinostat a class I histone deacetylase (HDAC) inhibitor in clinical trials. A novel PROTAC JMC-137 was identified as a HDAC1/2 and HDAC3 degrader in HCT116 cells. However, potency was compromised compared to previously identified class I HDAC PROTACs highlighting the importance in the choice of HDAC ligand, functional group for linker attachment and positioning in PROTAC design.

Graphical abstract: A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras

Supplementary files

Article information

Article type
Research Article
Submitted
28 Jun 2022
Accepted
05 Oct 2022
First published
01 Nov 2022
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2022,13, 1634-1639

A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras

J. M. Cross, M. E. Coulson, J. P. Smalley, W. A. Pytel, O. Ismail, J. S. Trory, S. M. Cowley and J. T. Hodgkinson, RSC Med. Chem., 2022, 13, 1634 DOI: 10.1039/D2MD00199C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements